Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
Last modified: | 08 June 2017 1.25 p.m. |
More news
-
07 February 2025
Four FSE start-ups take part in Academic Startup Competition
Four start-up companies founded by FSE scientists have been nominated to participate in the fifth edition of the Academic Start-up Competition.
-
03 February 2025
Flexible solar panels and a tattooed sensor
The black dots and lines on this plastic plate conduct electricity, and are as flexible as the plastic it is on. And that is special, Ranjita Bose, associate professor of Polymer Engineering, explains: ‘It’s a conductive polymer that combines the...
-
30 January 2025
Highlighted papers December 2024 - January 2025
Read our highlighted papers from December/January: new insights into electronics from 2D materials, and into the protein clumps that cause Huntington's disease.